动物辅助治疗（AAT）对 COVID-19 大流行期间精神分裂症患者社会交往和生活质量的影响：一项实验研究。

Effect of Animal-Assisted Therapy (AAT) on Social Interaction and Quality of Life in Patients with Schizophrenia during the COVID-19 Pandemic: An Experimental Study.

机构信息

National Taiwan University, Taiwan.

National Yang Ming Chiao Tung University, Taiwan.

出版信息

Asian Nurs Res (Korean Soc Nurs Sci). 2023 Feb;17(1):37-43. doi: 10.1016/j.anr.2023.01.002. Epub 2023 Jan 13.

DOI:10.1016/j.anr.2023.01.002

PMID:36646276

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9837379/

Abstract

PURPOSE

Most patients with schizophrenia exhibit low willingness to return to society because of negative social experiences. The COVID-19 pandemic led to severe social isolation for schizophrenia patients. However, animal-assisted therapy (AAT) can improve individuals' empathy, social functions, and quality of life. The study aimed to evaluate the effectiveness of AAT in improving social interactions and quality of life in patients with chronic schizophrenia during the COVID-19 pandemic.

METHODS

An experimental study was conducted, with six institutions for psychiatric rehabilitation in Taiwan as the case institutions. Patients in these institutions were randomly allocated to the experimental group, which received 60 minutes of AAT once a week for 12 weeks, or the control group, which engaged in routine discussion groups and watched short films about animals. Comparisons between the two groups were made before and after the intervention on social function, social adaptive function, and quality of life. Data were collected before the intervention (T1), immediately after the intervention (T2), and 3 months after the intervention (T3).

RESULTS

Comparison between groups showed that social functioning was significantly higher in the experimental group than in the control group at T2. However, there was no sign of improvement in social adaptive functions of the experimental group. The experimental group exhibited significantly higher quality of life than the control group at T2 and T3.

CONCLUSIONS

There was an impact of COVID-19 on the studied effects. AAT improved social functioning and quality of life in patients with chronic schizophrenia. The effect on quality of life lasted only up to 3 months after the intervention. AAT should be promoted for use as a community-based rehabilitation tool in patients with chronic schizophrenia.

TRIAL REGISTRATION

Chinese Clinical Trial Registry, ChiCTR2200061715. https://www.chictr.org.cn.

摘要

目的

大多数精神分裂症患者由于负面的社会经历而表现出较低的重返社会意愿。COVID-19 大流行导致精神分裂症患者严重的社会隔离。然而，动物辅助治疗（AAT）可以提高个体的同理心、社会功能和生活质量。本研究旨在评估 COVID-19 大流行期间 AAT 对改善慢性精神分裂症患者社会互动和生活质量的效果。

方法

进行了一项实验研究，以台湾的六家精神康复机构为案例机构。这些机构中的患者被随机分配到实验组，每周接受 60 分钟的 AAT，共 12 周，或对照组，进行常规讨论小组和观看关于动物的短片。在干预前后对两组进行社会功能、社会适应功能和生活质量的比较。数据在干预前（T1）、干预后立即（T2）和干预后 3 个月（T3）收集。